3 results
The primary objectives of this study are to establish the efficacy and safety of APL-2 compared to eculizumab in patients with PNH who continue to have Hb levels <10.5 g/dL despite treatment with eculizumab.
Primary objective: To evaluate the expected increase of the Microvascular Flow Index perioperative using a SDF-imaging device and the systemic inflammatory response by measuring inflammation biomarkers.Secondary objective: To learn more about the…
Primary objective: to investigate whether HPA-axis responses during the ACTH (Synacthen) stimulation are differentially influenced by distinct hormonal contraceptives, as compared to responses measured during the natural menstrual cycle (luteal…